KB
Kishore Babu Bathula
About Kishore Babu Bathula
Data last updated:
Kishore Babu Bathula is a Director at Suzikem Drugs Private Limited (since 2021) and Director at 2D Pharmaceuticals Private Limited (since 2020). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹3.26 Cr; the largest is Suzikem Drugs Private Limited at ₹1.83 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Aug 2021 | 1999 | ₹1.83 Cr (FY 2024) | Active | |
| Director | 26 Mar 2020 | 2020 | ₹1.43 Cr (FY 2024) | Active |
Board colleagues of Kishore Babu Bathula
| Name | DIN | Company | Designation |
|---|---|---|---|
| Junoothula Srivani Reddy | 07122036 | Suzikem Drugs Private Limited , 2D Pharmaceuticals Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kishore Babu Bathula
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kishore Babu Bathula
Kishore Babu Bathula currently holds 2 directorships: Suzikem Drugs Private Limited (Director, since 01 Aug 2021, revenue ₹1.83 Cr (FY 2024)); 2D Pharmaceuticals Private Limited (Director, since 26 Mar 2020, revenue ₹1.43 Cr (FY 2024)).
Kishore Babu Bathula was first appointed on 26 Mar 2020 as Director at 2D Pharmaceuticals Private Limited. The most recent appointment on record is 01 Aug 2021 at Suzikem Drugs Private Limited.
The 2 current companies of Kishore Babu Bathula that report revenue have a combined latest revenue of ₹3.26 Cr: Suzikem Drugs Private Limited ₹1.83 Cr (FY 2024); 2D Pharmaceuticals Private Limited ₹1.43 Cr (FY 2024).
The current boards of Kishore Babu Bathula's companies include Junoothula Srivani Reddy (Suzikem Drugs Private Limited).